Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy
- PMID: 24769471
- DOI: 10.1136/jnnp-2013-307223
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy
Abstract
Background: There is less data available regarding the characteristics of cognitive impairment in patients with amyotrophic lateral sclerosis (ALS) in a population-based series.
Methodology: Patients with ALS incident in Piemonte, Italy, between 2009 and 2011 underwent an extensive neuropsychological battery. Cognitive status was classified as follows: normal cognition, frontotemporal dementia (ALS-FTD), executive cognitive impairment (ALS-ECI), non-executive cognitive impairment (ALS-NECI), behavioural impairment (ALS-Bi), non-classifiable cognitive impairment. We also assessed 127 age-matched and gender-matched controls identified through patients' general practitioners.
Results: Out of the 281 incident patients, 207 (71.9%) underwent the neuropsychological testing; of these, 19 were excluded from the analysis due previous conditions affecting cognition. Ninety-one (49.7%) patients were cognitively normal, 23 (12.6%) had ALS-FTD, 36 (19.7%) ALS-ECI, 10 (5.5%) ALS-NECI, 11 (6.0%) ALS-Bi and 11 (6.0%) non-classifiable cognitive impairment, 1 had comorbid Alzheimer's disease. Patients with ALS-FTD were older, had a lower education level, and had a shorter survival than any other cognitive group. Of the nine cases with C9ORF72 mutation, six had ALS-FTD, two ALS-ECI and one was cognitively normal; one of the five patients with SOD1 mutations and one of the five patients with TARBDP mutations had ALS-Bi.
Conclusions: About 50% of Italian patients with ALS had some degree of cognitive impairment, in keeping with a previous Irish study, despite the largely different genetic background of the two populations. The lower educational attainment in patients with ALS-FTD indicated a possible role of cognitive reserve in ALS-related cognitive impairment. ALS-ECI and ALS-NECI may represent discrete cognitive syndromes in the continuum of ALS and FTD.
Keywords: ALS; DEMENTIA; EPIDEMIOLOGY.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
-
The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.JAMA Neurol. 2016 Apr;73(4):425-30. doi: 10.1001/jamaneurol.2015.4773. JAMA Neurol. 2016. PMID: 26903389
-
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.Neurodegener Dis. 2016;16(5-6):411-6. doi: 10.1159/000446802. Epub 2016 Aug 6. Neurodegener Dis. 2016. PMID: 27497596
-
Extensive genetics of ALS: a population-based study in Italy.Neurology. 2012 Nov 6;79(19):1983-9. doi: 10.1212/WNL.0b013e3182735d36. Epub 2012 Oct 24. Neurology. 2012. PMID: 23100398 Free PMC article.
-
Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse.Neurosci Biobehav Rev. 2016 Jan;60:12-25. doi: 10.1016/j.neubiorev.2015.11.006. Epub 2015 Nov 19. Neurosci Biobehav Rev. 2016. PMID: 26602023 Review.
-
[Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):302-6. doi: 10.4045/tidsskr.13.0049. Tidsskr Nor Laegeforen. 2014. PMID: 24518478 Review. Norwegian.
Cited by
-
Cognitive function in amyotrophic lateral sclerosis: a cross-sectional and prospective pragmatic clinical study with review of the literature.Neurol Sci. 2023 Dec 18. doi: 10.1007/s10072-023-07262-1. Online ahead of print. Neurol Sci. 2023. PMID: 38105306
-
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells.ACS Chem Neurosci. 2023 Dec 6;14(23):4240-4251. doi: 10.1021/acschemneuro.3c00629. Epub 2023 Nov 8. ACS Chem Neurosci. 2023. PMID: 37939393 Free PMC article.
-
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.BMJ. 2023 Oct 27;383:e075037. doi: 10.1136/bmj-2023-075037. BMJ. 2023. PMID: 37890889 Free PMC article. Review.
-
Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder.Nat Rev Neurol. 2023 Nov;19(11):655-667. doi: 10.1038/s41582-023-00878-z. Epub 2023 Oct 12. Nat Rev Neurol. 2023. PMID: 37828358 Review.
-
Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis.J Neurol. 2024 Jan;271(1):325-339. doi: 10.1007/s00415-023-11957-y. Epub 2023 Sep 15. J Neurol. 2024. PMID: 37713127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
